Phase II study of Cloretazine for the treatment of adults with recurrent glioblastoma multiforme

Cloretazine (VNP40101M) is a newly synthesized alkylating agent belonging to a novel class of alkylating agents called 1,2-bis(sulfonyl)hydrazines. Agents that belong to this class do not produce vinylating and chloroethylating species, and hence this class of alkylating agents is thought to have mi...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Badruddoja, Michael A., Penne, Kara, Desjardins, Annick, Reardon, David A., Rich, Jeremy N., Quinn, Jennifer A., Sathornsumetee, Sith, Friedman, Allan H., Bigner, Darell D., Herndon, James E., Cahill, Ann, Friedman, Henry S., Vredenburgh, James J.
Formato: Artigo
Lenguaje:Inglês
Publicado: Duke University Press 2007
Materias:
Clinical Investigations
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC1828104/
https://ncbi.nlm.nih.gov/pubmed/17108065
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1215/15228517-2006-022
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares